VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (0)
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
NASTOUPIL, LORETTA
One or more keywords matched the following items that are connected to
NASTOUPIL, LORETTA
Item Type
Name
Concept
Lymphoma, Mantle-Cell
Academic Article
Using primary site as a predictor of survival in mantle cell lymphoma.
Academic Article
Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
Academic Article
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphoma.
Academic Article
Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
Academic Article
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
Academic Article
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
Academic Article
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Academic Article
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Academic Article
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
Academic Article
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
Academic Article
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (=65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Academic Article
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement.
Search Criteria
Lymphoma Mantle Cell